Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.570
+0.140 (9.79%)
At close: Oct 21, 2026, 4:00 PM EDT
1.490
-0.080 (-5.10%)
Pre-market: Oct 22, 2026, 8:02 AM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $5.73 million as of October 21, 2026. It is the 44,320th most valuable company in the world and the 5,923rd biggest in the United States. Its market cap has decreased by 68.67% in one year.
Market Cap
5.73M
Enterprise Value
3.57M
1-Year Change
-68.67%
Global Rank
Country Rank
#5,923 United States
Category
ChartMarket Cap Chart
Since March 21, 2014, Pulmatrix's market cap has decreased from $30.40M to $5.73M, a decrease of -81.14%. That is a compound annual growth rate of -12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 5.73M | -29.21% |
| Dec 31, 2025 | 8.10M | -68.24% |
| Dec 31, 2024 | 25.50M | 275.00% |
| Dec 29, 2023 | 6.80M | -51.77% |
| Dec 30, 2022 | 14.10M | -42.68% |
| Dec 31, 2021 | 24.60M | -39.85% |
| Dec 31, 2020 | 40.90M | 137.79% |
| Dec 31, 2019 | 17.20M | 52.21% |
| Dec 31, 2018 | 11.30M | -61.95% |
| Dec 29, 2017 | 29.70M | 241.38% |
| Dec 30, 2016 | 8.70M | -85.74% |
| Dec 31, 2015 | 61.00M | 263.10% |
| Dec 31, 2014 | 16.80M | -44.74% |
| Mar 21, 2014 | 30.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 5.96M |
| Traws Pharma | 5.90M |
| Evogene | 5.68M |
| Processa Pharmaceuticals | 5.66M |
| Imunon | 5.60M |
| AIM ImmunoTech | 5.11M |
| Moleculin Biotech | 5.09M |
| NeuroSense Therapeutics | 4.88M |